Quality of individual INR control and the risk of stroke and bleeding events in <font color="red">atrial_2</font> <font color="red">fibrillation_2</font> <font color="red">patients_2</font> <font color="red">:_2</font> a nested case control analysis of the ACTIVE W study . 
<br>
<br> INTRODUCTION Time in therapeutic range ( TTR ) for international normalized ratio ( INR ) is an accepted quality measure of anticoagulation control in patient populations , but its usefulness for predicting stroke and bleeding in individuals is not well understood . 
<br> MATERIALS AND METHODS In a nested case control analysis among <font color="red">ACTIVE_1</font> <font color="red">W_1</font> <font color="red">study_1</font> <font color="red">patients_1</font> <font color="red">,_1</font> <font color="red">cases_1</font> <font color="red">with_1</font> <font color="red">stroke_1</font> <font color="red">and_1</font> <font color="red">cases_1</font> <font color="red">with_1</font> <font color="red">bleeding_1</font> <font color="red">were_1</font> <font color="red">separately_1</font> <font color="red">matched_1</font> <font color="red">with_1</font> <font color="red">controls_1</font> <font color="red">._1</font> Several anticoagulation quality measures were compared , overall and in a time - dependent manner . 
<br> RESULTS <font color="red">32_1</font> <font color="red">cases_1</font> <font color="red">with_1</font> <font color="red">ischemic_1</font> <font color="red">stroke_1</font> <font color="red">and_1</font> <font color="red">234_1</font> <font color="red">cases_1</font> <font color="red">with_1</font> <font color="red">bleeding_1</font> <font color="red">in_1</font> <font color="red">the_1</font> <font color="red">analysis_1</font> <font color="red">were_1</font> <font color="red">matched_1</font> <font color="red">in_1</font> <font color="red">a_1</font> <font color="red">4:1_1</font> <font color="red">ratio_1</font> <font color="red">to_1</font> <font color="red">122_1</font> <font color="red">and_1</font> <font color="red">865_1</font> <font color="red">controls_1</font> <font color="red">,_1</font> <font color="red">respectively_1</font> <font color="red">._1</font> Follow - up duration was 257±154days for the stroke analysis and 222±146days for the bleeding analysis . Compared with their respective controls , the study mean TTR of both stroke cases ( 53.9%±25.1 vs 63.4%±24.8 ; p=0.055 ) and bleeding cases ( 56.2%±25.4 vs 63.4%±26.8 ; p<0.001 ) was lower . Time below range for stroke and time above range for bleeding were only greater in the last month leading up to the event , not over the entire study period . Rather , over the entire study period bleeding cases spent more time below range than controls ( 26.8%±25.9 vs 20.8%±24.0 ; p=0.001 ) . 
<br> CONCLUSIONS TTR was lower in <font color="red">individual_1</font> <font color="red">AF_2</font> <font color="red">patients_2</font> <font color="red">with_1</font> <font color="red">stroke_1</font> <font color="red">or_1</font> <font color="red">bleeding_1</font> compared with <font color="red">matched_1</font> <font color="red">controls_1</font> <font color="red">in_1</font> <font color="red">ACTIVE_1</font> <font color="red">W._1</font> Maintaining a high TTR , with equal importance to avoid low and high INRs , is a relevant goal of individual patient treatment to prevent stroke and bleeding .